Annovis Bio, Inc. (ANVS)
NYSE · Healthcare
Annovis Bio, Inc. Balance Sheet 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 21.1M | 13.9M | 10.2M | 36.0M | 46.0M | 8.1M |
| Cash & Equivalents | 19.5M | 10.6M | 5.8M | 28.4M | 45.7M | 8.1M |
| Liabilities | ||||||
| Total Liabilities | 4.2M | 4.6M | 18.0M | 7.7M | 1.5M | 578,380 |
| Long-Term Debt | — | — | — | — | — | — |
| Equity | ||||||
| Shareholders' Equity | 16.9M | 9.3M | -7.8M | 28.3M | 44.5M | 7.5M |
Annovis Bio, Inc. Balance Sheet — FAQ
Annovis Bio, Inc. (ANVS) balance sheet over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANVS's balance sheet history?
The chart and table above show Annovis Bio, Inc.'s balance sheet by year and by quarter, including the growth rate.